ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

In Brief: Grace Powers Monaco Receives Lloyd Bentsen Award

July 21, 1995

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced

November 18, 1988

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014

House Appropriations Committee Approves $1.221 Bil. Budget For NCI In Fiscal 1986; NIH Gets 45.247 Bil.

October 4, 1985